Search research articles
Contact Us
Filters
Showing results (141-150 of 165) with videos related to
Page
of 17
Sort By:
British Journal of Haematology
|
December 21, 2022
SARS-CoV-2 infection and vaccination in patients with hairy-cell leukaemia
Enrico Tiacci, Alessandro Mancini, Monia Marchetti, et al.
The Oncologist
|
April 4, 2019
Lenalidomide in Pretreated Patients with Diffuse Large B-Cell Lymphoma: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice
Alessandro Broccoli, Beatrice Casadei, Annalisa Chiappella, et al.
European Journal of Haematology
|
September 25, 2023
Gaucher disease prevalence in 600 patients affected by monoclonal gammopathy of undetermined significance
Gaetano Giuffrida, Uros Markovic, Annalisa Condorelli, et al.
European Journal of Haematology
|
February 29, 2020
Brentuximab vedotin in association with bendamustine in refractory or multiple relapsed Hodgkin lymphoma. A retrospective real-world study
Emilio Iannitto, Alessandra Romano, Potito Rosario Scalzulli, et al.
Haematologica
|
June 29, 2019
First-line therapy with either bortezomib-melphalan-prednisone or lenalidomide-dexamethasone followed by lenalidomide for transplant-ineligible multiple myeloma patients: a pooled analysis of two randomized trials
Alessandra Larocca, Roberto Mina, Massimo Offidani, et al.
Cancer Medicine
|
November 6, 2020
The neutrophil to lymphocyte ratio (NLR) and the presence of large nodal mass are independent predictors of early response: A subanalysis of the prospective phase II PET-2-adapted HD0607 trial
Alessandra Romano, Chiara Pavoni, Francesco Di Raimondo, et al.
Journal of Clinical Medicine
|
June 29, 2019
Feasibility, Tolerability and Efficacy of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma Network
Concetta Conticello, Alessandra Romano, Vittorio Del Fabro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2011
Aspirin, warfarin, or enoxaparin thromboprophylaxis in patients with multiple myeloma treated with thalidomide: a phase III, open-label, randomized trial
Antonio Palumbo, Michele Cavo, Sara Bringhen, et al.
The Lancet. Haematology
|
October 4, 2016
The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study
Claudio Agostinelli, Andrea Gallamini, Luisa Stracqualursi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 24, 2018
Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial
Andrea Gallamini, Corrado Tarella, Simonetta Viviani, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 165) with videos related to
Sort By:
Page
of 17
British Journal of Haematology
|
December 21, 2022
SARS-CoV-2 infection and vaccination in patients with hairy-cell leukaemia
Enrico Tiacci, Alessandro Mancini, Monia Marchetti, et al.
The Oncologist
|
April 4, 2019
Lenalidomide in Pretreated Patients with Diffuse Large B-Cell Lymphoma: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice
Alessandro Broccoli, Beatrice Casadei, Annalisa Chiappella, et al.
European Journal of Haematology
|
September 25, 2023
Gaucher disease prevalence in 600 patients affected by monoclonal gammopathy of undetermined significance
Gaetano Giuffrida, Uros Markovic, Annalisa Condorelli, et al.
European Journal of Haematology
|
February 29, 2020
Brentuximab vedotin in association with bendamustine in refractory or multiple relapsed Hodgkin lymphoma. A retrospective real-world study
Emilio Iannitto, Alessandra Romano, Potito Rosario Scalzulli, et al.
Haematologica
|
June 29, 2019
First-line therapy with either bortezomib-melphalan-prednisone or lenalidomide-dexamethasone followed by lenalidomide for transplant-ineligible multiple myeloma patients: a pooled analysis of two randomized trials
Alessandra Larocca, Roberto Mina, Massimo Offidani, et al.
Cancer Medicine
|
November 6, 2020
The neutrophil to lymphocyte ratio (NLR) and the presence of large nodal mass are independent predictors of early response: A subanalysis of the prospective phase II PET-2-adapted HD0607 trial
Alessandra Romano, Chiara Pavoni, Francesco Di Raimondo, et al.
Journal of Clinical Medicine
|
June 29, 2019
Feasibility, Tolerability and Efficacy of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma Network
Concetta Conticello, Alessandra Romano, Vittorio Del Fabro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2011
Aspirin, warfarin, or enoxaparin thromboprophylaxis in patients with multiple myeloma treated with thalidomide: a phase III, open-label, randomized trial
Antonio Palumbo, Michele Cavo, Sara Bringhen, et al.
The Lancet. Haematology
|
October 4, 2016
The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study
Claudio Agostinelli, Andrea Gallamini, Luisa Stracqualursi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 24, 2018
Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial
Andrea Gallamini, Corrado Tarella, Simonetta Viviani, et al.
Page
of 17